Michael J. Thirman

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat et al. · New England Journal of Medicine · 2020 · 2.8K citations · Full text

Medicine, Pharmacotherapy, Medical Oncology +3

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

Courtney D. DiNardo, Keith W. Pratz, Anthony Letai et al. · The Lancet Oncology · 2018 · 712 citations

Medicine, Hematology, Pharmacology +9

Rearrangement of the MLL Gene in Acute Lymphoblastic and Acute Myeloid Leukemias with 11q23 Chromosomal Translocations

Michael J. Thirman, Heidi J. Gill, Robert C. Burnett et al. · New England Journal of Medicine · 1993 · 509 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 468 citations · Full text

Medicine, Molecular Biology, Oncology +13

Distinct microRNA expression profiles in acute myeloid leukemia with common translocations

Zejuan Li, Jun Lü, Miao Sun et al. · Proceedings of the National Academy of Sciences · 2008 · 462 citations · Full text

Life Sciences, Molecular Biology, Oncology +17